Herein, we revealed that a novel inactivated lncRNA, CANT1, at chromosome 6p22.3 modulates RB tumorigenesis through the epigenetic activation of PI3Kγ expression, thus enhancing PI3K/Akt signaling and accelerating tumor progression (Fig. 7e). The gene discussed is RB1; the disease is neoplasm.